How can Cosentyx (secukinumab) change how well vaccines work?
Cosentyx (secukinumab) is an immune-modulating biologic that blocks interleukin-17A (IL‑17A). Because it dampens parts of the immune response involved in inflammation, it can, in theory, make vaccine responses different from what you would see without the medication. The practical effect depends on the type of vaccine (live vs. non-live) and on what immune pathway that vaccine relies on.
Are live vaccines safe to take while on Cosentyx?
Live vaccines are generally avoided in people taking immunomodulating biologics like Cosentyx. Live vaccines can replicate and are more likely to cause disease in people whose immune defenses are suppressed. This is why clinicians often recommend reviewing vaccination plans before starting therapy and holding off on live vaccines during treatment.
Do inactivated vaccines still work on Cosentyx?
Inactivated vaccines (including most routine flu shots) do not contain live organisms. They are generally considered usable while on Cosentyx, but the immune response may be reduced compared with people not taking IL‑17 blockade. In practice, many patients can still be vaccinated safely, but they may need timing coordination around dosing and should follow public health guidance on booster schedules to maintain protection.
What timing matters—before starting or around doses?
Clinicians often try to vaccinate before initiating Cosentyx when possible, so the immune system can mount a stronger response. If you’re already on treatment, timing may still matter for how strongly your body responds, but the key goal is to use non-live vaccines when vaccination is needed and to align with the clinician’s vaccination schedule.
What vaccines are people most concerned about?
The vaccine questions that come up most often with IL‑17 blockers are:
- Influenza (seasonal flu shots)
- COVID-19 vaccines
- Pneumococcal vaccines
- Shingles (usually the non-live option, depending on local availability and guidance)
- Travel vaccines (which vary by destination and may include live formulations)
If a vaccine is live, it becomes the biggest issue with Cosentyx. If it is non-live, clinicians usually proceed but may expect a somewhat altered immune response.
Should you delay Cosentyx to improve vaccine response?
Because Cosentyx is ongoing for inflammatory disease control, decisions about pausing it are individualized. The main general approach is to avoid live vaccines and to use available non-live vaccines. Whether holding doses improves antibody levels versus increasing the risk of disease flare depends on your condition and your clinician’s assessment.
When should you talk to your clinician urgently?
Talk with your clinician before vaccination if:
- The vaccine you’re considering is live (or you’re unsure)
- You’re planning to start Cosentyx soon
- You have a history of frequent infections or prior problems with vaccines
- You’re immunocompromised for other reasons (other biologics, high-dose steroids, chemotherapy)
Sources
I don’t have enough provided source material in this chat to cite specific studies or official vaccine guidance about Cosentyx’s effect on vaccine efficacy. If you share the source text or links you want me to use, I can produce a cited, evidence-based answer.